Trial intelligence / Profile preview

POP-II: Drug Therapy Schedules for Morbidly Obese Patients

NCT01097148Phase 4Completed

Start
Nov 2009
Primary completion
Apr 2010
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atracurium in class III obesity. Started Nov 2009; status: completed.

02

Drugs

atracurium
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT01097148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01097148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call